Molecular determinants of loperamide and N-desmethyl loperamide binding in the hERG cardiac K+ channel.
暂无分享,去创建一个
Roy J Vaz | Roy J. Vaz | Jiesheng Kang | D. Rampe | Jiesheng Kang | Yongyi Luo | David Rampe | Yongyi Luo
[1] R. Friesner,et al. New insights about HERG blockade obtained from protein modeling, potential energy mapping, and docking studies. , 2006, Bioorganic & medicinal chemistry.
[2] T. Macgregor,et al. Interaction of Ritonavir-Boosted Tipranavir with Loperamide Does Not Result in Loperamide-Associated Neurologic Side Effects in Healthy Volunteers , 2005, Antimicrobial Agents and Chemotherapy.
[3] Yumi N Imai,et al. Docking model of drug binding to the human ether-à-go-go potassium channel guided by tandem dimer mutant patch-clamp data: a synergic approach. , 2009, Journal of medicinal chemistry.
[4] S. Borron,et al. Intentional Misuse and Abuse of Loperamide: A New Look at a Drug with "Low Abuse Potential". , 2017, The Journal of emergency medicine.
[5] M. Cook,et al. Loperamide-Induced Torsades de Pointes: A Case Series. , 2017, The Journal of emergency medicine.
[6] Kelly C. Chang,et al. Characterization of loperamide-mediated block of hERG channels at physiological temperature and its proarrhythmia propensity. , 2017, Journal of pharmacological and toxicological methods.
[7] State dependent dissociation of HERG channel inhibitors , 2007 .
[8] Roy J. Vaz,et al. Proarrhythmic mechanisms of the common anti-diarrheal medication loperamide: revelations from the opioid abuse epidemic , 2016, Naunyn-Schmiedeberg's Archives of Pharmacology.
[9] T. Flagg,et al. Potent Inhibition of hERG Channels by the Over-the-Counter Antidiarrheal Agent Loperamide. , 2016, JACC Clinical Electrophysiology.
[10] R. Friesner,et al. Novel procedure for modeling ligand/receptor induced fit effects. , 2006, Journal of medicinal chemistry.
[11] I. Papoutsis,et al. “Poor man’s methadone” can kill the poor man. Extra-medical uses of loperamide: a review , 2017, Forensic Toxicology.
[12] C. Wandel,et al. Increased drug delivery to the brain by P‐glycoprotein inhibition , 2000, Clinical pharmacology and therapeutics.
[13] Roderick MacKinnon,et al. Cryo-EM Structure of the Open Human Ether-à-go-go-Related K+ Channel hERG , 2017, Cell.
[14] Jun Chen,et al. A structural basis for drug-induced long QT syndrome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[15] Peter E. Wu,et al. Clinical Review: Loperamide Toxicity , 2017, Annals of emergency medicine.
[16] Nigel J Waters,et al. Validation of a rapid equilibrium dialysis approach for the measurement of plasma protein binding. , 2008, Journal of pharmaceutical sciences.
[17] S. Nattel. An Emerging Malignant Arrhythmia Epidemic Due to Loperamide Abuse: Underlying Mechanisms and Clinical Relevance. , 2016, JACC. Clinical electrophysiology.